Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Temozolomide

EU orphan designation number: EU/3/16/1733   
Active ingredient: Temozolomide
Indication: Treatment of glioma
Sponsor: Double Bond Pharmaceutical AB
Virdings Allé 32B, SE-75 450 Uppsala, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2016 Orphan designation EMA/OD/085/16 (2016)5640 of 29/08/2016